Zymeworks: Peers

The FY2025 (Dec) proxy of Zymeworks names 19 peer companies for pay. Among Zymeworks and these peers, CEO pay was 4th highest of 9 and total shareholder return was 2nd highest of 9.

4th highest of 9in Zymeworks and its pay peers, FY2025 (Dec) by CEO pay:

$4.2M$27.8M

2nd highest of 9in Zymeworks and its pay peers, FY2025 (Dec) by total shareholder return:

$20$414

Pay peer group, FY2025 (Dec) proxy

Cogent Biosciences
Arcus Biosciences
Immunome
Anaptysbio
Cullinan Therapeutics
Kura Oncology
Relay Therapeutics
Regenxbio
Alector, Inc.Not disclosedNot disclosed
Bicycle TherapeuticsNot disclosedNot disclosed
C4 TherapeuticsNot disclosedNot disclosed
ErascaNot disclosedNot disclosed
IGM Biosciences, Inc.Not disclosedNot disclosed
Iteos TherapeuticsNot disclosedNot disclosed
MacroGenics, Inc.Not disclosedNot disclosed
Replimune Group, Inc.Not disclosedNot disclosed
Sutro Biopharma, Inc.Not disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
XencorNot disclosedNot disclosed
19 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.